Press Releases | Alexion Pharmaceuticals, Inc

About Alexion
Patient Focus
Products
Research & Development
Responsibility
Careers
Select a Country
- North America
  - Canada
  - USA
- Latin America
  - Argentina
  - Brazil
  - Colombia
  - Mexico
- Europe, the Middle East & Africa
  - Alexion Europe
  - Belgium
  - Denmark
  - France
  - Germany
  - Ireland
  - Italy
  - Netherlands
  - Norway
  - Russia
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - UAE
  - UK
- Asia Pacific
  - Australia
  - China
  - India
  - Japan
Investors
News
Contact

Home
»
Newsroom
»
Press Releases

Press Releases

Press Releases

Alexion Exercises Option for Two Additional GalXC™ RNAi Programs for Complement-Mediated Targets Under Collaboration With Dicerna™
December 16, 2019
HTML PDF
Alexion Issues Statement on Path to Value Creation
December 6, 2019
HTML PDF
Alexion to Present at the 2019 Evercore ISI HealthCONx
November 26, 2019
HTML PDF
SOLIRIS® (eculizumab) Receives Approval in Japan for the Prevention of Relapse in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
November 22, 2019
HTML PDF
Alexion to Present at the 2019 Stifel Healthcare Conference
November 13, 2019
HTML PDF
Alexion Announces Data Presentations at 61st American Society of Hematology Annual Meeting
November 6, 2019
HTML PDF
Alexion Reports Third Quarter 2019 Results
October 23, 2019
HTML PDF
Alexion Receives FDA Approval for ULTOMIRIS® (ravulizumab-cwvz) for Atypical Hemolytic Uremic Syndrome (aHUS)
October 18, 2019
HTML PDF
Alexion to Acquire Achillion
October 16, 2019
HTML PDF
Alexion Announces Appointment of Tanisha Carino, Ph.D., as Chief Corporate Affairs Officer
October 10, 2019
HTML PDF